COVID-19 Updates
From the Journals
More evidence shows COVID-19’s link to risk for autoimmune disease
Patients with more severe COVID-19 that required hospitalization in the ICU were more likely to develop vasculitis, alopecia totalis, and several...
News
Preparing for the viral trifecta: RSV, influenza, and COVID-19
From the Journals
COVID-19 virus infects coronary vasculature
“Our data conclusively demonstrate that SARS-CoV-2 is capable of infecting and replicating in macrophages within the coronary vasculature of...
From the Journals
Study: Unexpected vaginal bleeding rises after COVID vaccination
Researchers suggested it could have been connected to the SARS-CoV-2 spike protein in the vaccines.
From the Journals
People with long COVID have specific blood biomarkers, study says
The findings may be a step toward creating blood tests to positively identify people with long COVID so specialized treatments can be employed.
From the Journals
Study: Antiviral med linked to COVID mutations that can spread
“There aren’t any widely circulating variants that have the signature. At the moment there’s nothing that’s transmitted very widely that’s due to...
From the Journals
Paxlovid weaker against current COVID-19 variants
But when looking at death alone, the antiviral was still highly effective.
Latest News
Creatine may improve key long COVID symptoms: Small study
A small randomized, controlled study finds a significant reduction in hallmark long COVID symptoms, but there are important unanswered questions...
Latest News
Paxlovid and Lagevrio benefit COVID outpatients in Omicron era
In a update of the rapid practice point guideline for outpatient treatment of COVID-19, the American College of Physicians found that nirmatrelvir...
From the Journals
COVID booster may transiently raise glucose levels in T1D
“Clinicians, pharmacists, and other health care providers may need to counsel people with T1D to be more vigilant with glucose testing and insulin...
Conference Coverage
SGLT2 inhibitors: No benefit or harm in hospitalized COVID-19
“I think the most important take-home message here is that the use of these medications appears to be safe even in really acutely ill hospitalized...